Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway

Liraglutide, as a glucagon-like peptide-1 analogue, is used to treat type 2 diabetes mellitus and obesity. Previous findings have demonstrated the effects of liraglutide on adipogenesis; however, the underlying mechanism involved in this process remains to be elucidated. In the present study, to cer...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yongmei, Du, Jianying, Zhu, Endong, Zhang, Juanjuan, Han, Jie, Zhao, Wei, Sun, Bei, Tian, Derun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802226/
https://www.ncbi.nlm.nih.gov/pubmed/29344656
http://dx.doi.org/10.3892/mmr.2018.8438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802226/
https://www.ncbi.nlm.nih.gov/pubmed/29344656
http://dx.doi.org/10.3892/mmr.2018.8438

Ejemplares similares